Channel Opportunity Leverage the acquisition by Amplity Health to access a pharmaceutical commercialization network and offer real world data insights to pharma and CROs. Use data to support evidence generation, market access analytics, and payer discussions.

Data Asset Strength A deidentified database of narrative medical records spanning major specialties and states enables refined outcomes research, safety surveillance, and regulatory submissions. Target biopharma, CROs, and payers seeking customized analytics and real world evidence.

NLP Partnerships Past collaboration with an NLP focused partner shows capability to turn free text medical narratives into structured insights. Offer NLP driven data extraction, query tooling, and customizable dashboards to research teams.

RWE Market Need There is growing demand for real world data solutions to complement centralized trial results. Position as a nimble provider offering fast data access, tailored queries, and white label options to accelerate studies.

Partnership Approach Small team with a unique deidentified dataset offers partnership friendly economics. Pursue licensing data as a service or white label arrangements with Amplity or other large health tech firms to scale reach.